Birmingham, West Midlands -- (SBWIRE) -- 01/02/2014 -- Value Penny Stocks issues special report on Dendreon Corporation (NASDAQ:DNDN), Huntington Bancshares Incorporated (NASDAQ:HBAN), Brocade Communications Systems, Inc. (NASDAQ:BRCD), Idera Pharmaceuticals Inc (NASDAQ:IDRA).
Dendreon Corporation (NASDAQ:DNDN) opened its last trade at the price of $2.99. Its closing price was $2.99 after losing -1.97% for the day. The company traded with the total volume of 4,191,157 shares, while its average trading volume remained 3.80 million shares. The beta of this stock stands at 5.04. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers.
Has DNDN Found The Bottom and Ready To Move Up? Find Out Here
Huntington Bancshares Incorporated (NASDAQ:HBAN) percentage change surged 0.73% to close at $9.65 with the total traded volume of 4,262,576 shares, along with average volume of 8.50 million shares. The 52 week range of the stock remained $6.48 - $9.73, while its day lowest price was $9.58. The share price hit the day highest price of $9.68. Huntington Bancshares Incorporated operates as the holding company for The Huntington National Bank that provides commercial, small business, and consumer banking services. The company’s Retail and Business Banking segment offers various financial products and services, including checking, savings, and money market accounts.
For How Long HBAN’s Gloss will Attract Investors? Find out via this report
Brocade Communications Systems, Inc. (NASDAQ:BRCD) traded on volume of 4,125,419 shares in the last session against average volume of 4.59 million shares. The company started its trading session with the price of $8.75 and closed at $8.86 by scoring +1.08%. Brocade Communications Systems, Inc. provides Internet protocol based networking solutions and storage area networking (SAN) solutions to businesses and organizations worldwide.
Will BRCD Continue To Move Higher? Find Out Here
Idera Pharmaceuticals Inc (NASDAQ:IDRA) started its last trading session with the price of $4.22 and closed at $4.63 by scoring 10.24%. The stock traded with total volume of 4,117,813 shares, while the average trading volume remained 1.58 million shares. The beta value of this stock stands at 1.94. Day range for the stock was $4.12 - $4.75. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates. It is developing drug candidates designed to modulate immune responses mediated through Toll-like Receptors (TLRs).
Why Should Investors Buy IDRA After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)